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A novel amphiphilic core-corona hyperbranched polymer, composed of 3-ethyl-3-
(hydroxylmethyl) oxetane (EHMO) and PEGylated EHMO (EHMOPEG), was synthesized 
through cationic ring opening polymerization. Nuclear Magnetic Resonance spectroscopy 
(NMR), Dynamic Light Scattering (DLS), and Fourier Transform Infrared spectroscopy (FTIR) 
were used to characterize the polymer structure and degree of branching. It was found that the 
degree of branching (DOB) of the polymer was affected by the weight % ratios of 
EHMO/EHMOPEG used in polymerization. As the weight % ratio of EHMO/ EHMOPEG 
decreased, the DOB was observed to increase. Polymeric particles based on the synthesized 
polymer were prepared using the O/W (Oil in Water) solvent emulsion method and evaluated for 
 x 
drug delivery. Scanning Electron Microscopy (SEM) and Dynamic Light Scattering (DLS) were 
used to characterize the size and shape of the particles. The obtained particles were found to be 
spherical in shape and have a narrow size distribution. Camptothecin (CPT) was used as the 
model drug for drug encapsulation and controlled release studies. The loading and encapsulation 
efficiencies of the particles ranged between 60% and 80%. Cytotoxicity studies carried out with 
human skin fibroblasts indicated that as the weight % ratio of the EHMO/ EHMOPEG decreased 
the biocompatibility of the polymer increased. In vitro drug release studies showed that the CPT 
could be released over an extended period of time. The efficacy of the drug released from the 
particles was demonstrated by the MTT assay on HN12 cells. The results showed that the 
cellular activity decreased as the amount of drug released from the particles increased over a 
span of 72 hours. The synthesized polymer represents a new family of hyperbranched 
macromolecule with potential for drug delivery.  
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CHAPTER 1 INTRODUCTION 
 
 For a long time, pharmaceutical formulations mostly comprised quick acting and 
simple substances that could be easily administered either orally or injected directly.1 
However, over the last few decades, the scenario has been changing and the need for 
formulations with controlled release and specificity has increased significantly.1 Various 
efforts are being centered on not only the synthesis of better vehicles to carry drug 
formulations but also their administration routes. The encapsulation of drugs into a 
delivery vehicle for site specific delivery has become an important strategy to reduce 
degradation of drugs, which otherwise reduces and limits their efficacy before they reach a 
specified site for action.2 Additionally, these vehicles are designed to overcome various 
problems such as drug toxicity, burst release, etc.1, 2 A number of drug delivery systems 
have been developed for drug delivery, including liposomes, microspheres, and 
nanoparticles.3, 4 Polymeric drug delivery systems are attractive vehicles for drug delivery 
as they can serve as a means of effectively controlling drug dose and for targeting specific 
regions in the body.1 The use of polymeric drug delivery systems for example poly(lactic 
acid) based delivery system, dated back to early 1970s.1 Most polymers being investigated 
for drug-delivery applications are either linear (non-branched) or cross-linked in nature.5-7 
Recent developments in polymers with hyper branched and defined architectures have 
opened new opportunities for developing more efficient drug delivery systems.  
 2 
This thesis work involves synthesis and characterization of a novel amphiphilic core 
corona hyperbranched polymeric system. This polymeric system was explored as a carrier 
for delivery of hydrophobic drugs. Cationic ring opening polymerization was used for the 
synthesis using 3-ethyl-3-(hydroxymethy) oxetane (EHMO) and PEGylated EHMO 
(EHMOPEG) as monomers. Four different polymers were prepared by varying the molar 
ratios of EHMO/ EHMOPEG for this study. Techniques such as Fourier Transform Infrared 
spectroscopy, Scanning Electron Microscopy, Dynamic Light Scattering, Differential 
Scanning Calorimetry and Nuclear Magnetic Resonance spectroscopy were used to 
characterize the synthesized monomer and polymers. This hyperbranched polymer was 
further formulated into particles using single oil-in-water (O/W) emulsion/solvent method 
and evaluated for delivery of anticancer drug camptothecin. 
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CHAPTER 2 BACKGROUND 
 
2.1 A brief history of branched polymers 
Vogtle was the first to introduce the idea of hyperbranched polymer.8 This study led to the 
concept of insistent growth, which was applied to the synthesis of low molecular weight 
amines.8 Before this discovery, there were only three major polymer classes based on 
polymer architecture –  linear, crosslinked and branched.5-8 After the iterative reaction 
scheme was identified, many researchers have developed interests in exploring synthesis 
and applications of such hyperbranched structures. Macromolecular architectures of 
branched polymers can be divided into three major classes: dendrimers3, dendrigrafts3, and 
hyperbranched polymers.5 Since then a number of hyperbranched polymers including 
dendrimers have been developed, such as poly(propylene imine) (PPI) dendrimers by 
Wörner/ Mülhaupt9 and Brabender-van den Berg/Meijer10, poly(amidoamine) (PAMAM) 
dendrimers by Tomalia et al.11, 12 and dendri-poly(ethers) along with dendripoly(thioethers) 
by Newkome et al.13, 14  
 
2.2 Dendrimers 
Dendrimers are the best characterized subclass. They possess unique properties such as 
mono-dispersity and highly symmetrical structure. Their basic architectural components 
include a core, interior units comprising of various branches and surface functional 
groups.7, 8, 15 Dendrimers are formed by repetitive sequence of reaction steps, where with 
 4 
each successive step molecular weight and generation number become higher than the 
previous7. Two common ways applied for dendrimer synthesis are convergent and 
divergent methods. The divergent method as shown in Figure 1,15, 16 involves the addition 
of monomer and then the subsequent building up of the structure from the core eventually 
proceeding outwards to the periphery of the molecule.7, 8, 15 The symmetric branched 
structure is formed by covalently attaching a new generation to the reactive sites present in 
the core.7, 15 In this method the number of reactions increase exponentially for each 
subsequent generation.7, 15 Reaction at each step of synthesis must be completed in order to 
avoid any trailing generation that might form if some branches are shorter than the others. 
These impurities might impair the functionality and symmetry of the dendrimer.7, 15    
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Figure 1: Divergent method of dendrimer synthesis.  
 
The convergent method as shown in Figure 2, 15, 16uses small terminal moieties or groups 
attached to a monomer with masked functional groups for initiating the process.7, 15 In this 
method, the reaction and growth proceed from outside to inward towards the core.7, 15 This 
method has advantages including easy removal of impurities to help sustain the 
functionality of dendrimer, and reduction of the number of transformations required to 
connect every consecutive generation.7, 15 However, sterical hindrances cause crowding 
and hence the generation of dendrimers formed by this method is not very high.7, 15 
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Figure 2: Convergent method of dendrimer synthesis.  
 
Some examples of the polymers prepared by the divergent method are poly(amidoamine) 
(PAMAM)11, 12 and poly(propylene imine) (PPI) dendrimers11, 12 and those prepared by the 
convergent method are poly(benzyl ether) dendrimers.11, 12 Their molecular weights can be 
controlled as required.7, 17 The number of their surface functional groups increases 
exponentially while their diameter increases linearly with increase in generation.5 Their 
surface functional groups play a significant role in determining material properties and can 
be modified to get a desired property.5, 18 Dendrimers, have lower viscosities and higher 
solubility than their linear analogues.5, 19  
 
2.3 Dendrigraft polymers 
Another subset of hyperbranched polymers are dendrigraft polymers,20, 21 which are known 
as semi-controlled polymers as their structures are not as well defined as dendrimers.3 
Similar to dendrimers, dendrigraft polymers consist of a core, interior with branches and 
various terminal functional groups. However, unlike dendrimers, their grafting sites are 
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distributed quite randomly.3 They can be prepared by divergent ‘grafting onto’ method as 
shown in Figure 3.21 Some examples of successfully synthesized dendrigrafts are poly (2-
ethyl-2-oxazoline) (PEOX) oligomers grafted onto linear poly(ethylene imine) substrates.20   
linear
functionalization
functionalization
Generation 0
Generation 1  
Figure 3: Synthesis of dendrigraft polymer.  
 
2.4 Hyperbranched polymers 
Hyperbranched polymers have received considerable attention in recent years due to their 
versatile architecture and many potential applications.3, 22 They have been exploited as 
drug delivery vehicles because their architecture can be aptly modulated to obtain desired 
properties. For instance, functional groups on the surface can be engineered to influence 
their properties such as glass transition temperature, solubility, mechanical properties, and 
melt viscosity.22, 23 Hyperbranched polymers are poly-disperse but less complicated to 
 8 
synthesize when compared to dendrimers.22, 24, 25 Their cost-effective manufacturing makes 
them attractive for large scale applications. One of the most attractive features of 
hyperbranched polymers is the absence of entanglement and low viscosity in bulk and 
solution.5  Different methods including self poly-condensation polymerization, proton 
transfer polymerization, and ring opening chain polymerization have been exploited for the 
synthesis of hyperbranched polymers.22, 24 
 
2.4.1 Methods for synthesis of hyperbranched polymers  
There are two major methods used for the polymerization of hyperbranched polymers: 
single monomer methods (SMM),26 where only monomer ABx is required for 
polymerization; and double monomer methods (DMM),26 where the polymerization 
requires  two different types of monomers.  
 
2.4.1.1 Polycondensation of ABx monomers 
Self poly-condensation is a one step reaction, which is useful for polymerization of ABx 
monomers.27-29 Examples of polymers prepared by this method are polyethers,27-29 
polyesters,30 and polycarbonates.31 The reaction is shown in the following scheme (Figure 
4).22  
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Figure 4: Self poly-condensation of AB2 monomer 
 
Requirements for self poly-condensation vinyl polymerization (SCVP) are a double bond 
and an initiation moiety in the monomer. The reaction takes place in the following manner 
(Figure 5).22 
 
 
Figure 5: Self poly-condensation vinyl polymerization  
 
2.4.1.2 Proton-transfer polymerization (PTP) 
PTP is dependent on the basicity and acidity of monomers as shown in Figure 6.32 This 
concept has been used for synthesis of various hyperbranched polymers such as an 
aliphatic hyperbranched polyether derived from a diepoxide and a trifunctional alcohol 
group.33, 34  
 10 
 
Figure 6: Proton transfer polymerization.  
 
2.4.1.3 Ring-opening polymerization (ROP) 
The third method is the ring opening polymerization which was earlier known as multi-
branching polymerization since the number of chain terminals increases with progression 
of polymerization.7, 24 Molecular weight distribution of the polymers generated by this 
method can be controlled by moderating the addition of proper initiators to generate 
various numbers of active sites.7, 24 One of the examples of ring opening polymerization is 
shown in Figure 7.22  
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Figure 7: Ring opening polymerization.  
 
2.4.2 Degree of Branching 
For maximizing the advantages of hyperbranched polymer, it is important to understand 
their structure-property relationship.6, 35 Degree of branching is one of the most important 
aspects of this relationship. Hyperbranched polymers consist of dendritic unit (D), linear 
unit (L), and terminal unit (T) as shown in Figure 8,22 which influence the degree of 
branching of the polymer.6, 35  
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Figure 8: Degree of branching. 
 
Degree of branching can be calculated by the following equation.6, 23   
    
Values for dendritic units, linear units, and terminal units can be determined by integrating 
the corresponding peaks in 13C NMR. Degree of branching has a huge impact on 
hyperbranched polymer’s physical and chemical properties. Recently it was reported that 
the degree of branching could be controlled by many factors including monomer to catalyst 
ratio, and temperature. It has been proposed that the degree of branching increases with 
temperature.36  
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2.4.3 Properties of hyperbranched polymers  
Glass transition temperature governs the thermal behavior of hyperbranched polymers.37  
Factors such as chain end groups, molar mass and macromolecular composition influence 
the glass transition temperature of a given polymer.37 Increase in the degree of branching 
results in a change of the glass transition temperature, which can be explained using free 
volume concept.38 Particularly, polymers with more branches occupy more free space. 
Therefore, the restriction in the movement of the chains can only be overcome at higher 
temperature.5, 22, 24 Due to less entanglements and more organized branched structure, 
hyperbranched polymers have different mechanical properties from crosslinked polymers5, 
22, 24 Because of their globular structure, chain extension and orientation become difficult, 
hence resulting in strain hardening. Melt viscosity of hyperbranched polymers is much 
lower than that of their linear polymers.20, 21 Intrinsic viscosity (as described by the Mark-
Houwink equation) and hydrodynamic volumes are lower for hyperbranched polymers 
than for their linear analogues due to differences in their structural arrangement.5  
 
2.5 Drug delivery  
Drug delivery systems can help improve the specificity, bio-distribution and efficacy of 
drugs.1, 2 Since polymers have a capacity of being customized, they are good substitutes to 
replace the earlier established carriers such as viruses, and protein conjugates which have 
limitations such as poor stability and non-specificity.1, 2 Several commonly used methods 
for drug delivery based on polymers are polymer-drug conjugate,1, 2 drug encapsulating 
polymeric micelles,1, 2 and multicomponent polyplexes.1, 2 Encapsulation of a drug in the 
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polymeric micelles is realized by trapping the drug in the internal core through 
hydrophobic-hydrophobic interactions. Polymer-drug conjugates, on the other hand, are 
usually prepared by covalently coupling drug to polymer.1, 5 Polymeric nanoparticles have 
shown great promise as drug carriers in the biomedical field.4, 39 Nanoparticles can be one 
of two types: firstly monolithic nanocapsules1, 2, 39 in which drug is encapsulated in the 
hydrophobic or hydrophilic core surrounded by a shell; and secondly nanospheres1, 2, 39 
which can encapsulate the drug through out the entire matrix.1, 2 They help overcome 
hurdles that are usually faced with direct administration of drugs. They increase the 
solubility and action specificity of drugs.2,23,39 They are small in size and easy to 
administer and result in high cellular uptake. 2, 39 The most important property they possess 
is their ability to release the entrapped drug in a well controlled manner.1, 23 Amphiphilic 
polymers play an important role in the delivery of hydrophobic drugs.23, 39 They arrange 
themselves in a manner where the hydrophobic drug can be encapsulated in the polymer’s 
hydrophobic. Meanwhile, a hydrophilic PEG layer offers stealth properties to the vehicle 
and help extend its half life.1, 2, 23  
 
3-ethy-3-(hydroxymethyl) oxetane was selected as the monomer 1 for polymerization as it 
is a trifunctional monomer which can be reacted to form a hyperbranched structure. 
Monomer 2 was synthesized by attaching a PEG chain to monomer 1 to provide 
biocompatibility to the monomer, which could further be imbibed in the polymer.
 15 
 
 
CHAPTER 3 MATERIALS AND METHODS 
 
3.1 Materials 
 
Table 1: List of materials used 
 
Material                                                               Abbreviation 
3-ethyl 3-(hydroxymethyl) oxetane 
(monomer 1)                                                              
EHMO 
 
Boron trifluoride diethyl etherate     
Dichloromethane                                                                                              DCM
Chloroform   
Methanol  
De-ionized water                                                                                             DI water
Triethyl anhydride                                                                                            TEA 
4-nitro phenyl chloroformate                                                                            NPC
Tetrahydrofuran                                                                                                THF
Dimethylformamide                                                                                          DMF
Dimethyl Sulfoxide                                                                                           DMSO
Hexane  
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3.2 Equipment 
 
Table 2: List of equipments and machines used:  
 
Equipment name                                                                  Use 
 
Nuclear Magnetic Resonance 
(NMR)                         
400 MHz spectrometer was used to                                                          
carry out proton and carbon13                                                                  
measurements 
 
Dynamic Light Scattering   
(DLS)                            
To measure the hydrodynamic radius  
of nanoparticles and also to measure                     
molecular weight of the polymers         
                                                                     
Flexi-dry MP controlled rate freezer 
(FTS systems, Inc.)                                       
To freeze dry the samples 
Differential Scanning Calorimetry 
(DSC)                                                               
To determine the glass transition 
temperature of the polymers                                                     
Scanning Electron Microscopy  
Model EVO 550                                                                 
To take photographs of the nano- 
particles 
UV-Vis spectrophotometer                           To conduct quantitative analysis for 
drug release studies                                                                   
Eppendorf Centrifuge Model- F-45-24-
11 
To centrifuge samples to separate 
liquid phase from suspended phase                                                          
Fourier Transform Infrared 
spectroscopy (FT-IR) 
For characterization of the polymer 
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3.3 Synthesis 
 
3.3.1 Monomer synthesis 
PEGylated EHMO (i.e., monomer 2) was synthesized by substituting the hydroxyl group 
present on 3-ethyl 3-(hydroxymethyl) oxetane with NH2-PEG-OCH3 (MW= 2000 daltons 
and 550 daltons) group as described in a previously reported method.23  
 
Method of preparation of monomer 2:  
As shown in Scheme 1, monomer 1 (0.29 g) was weighed and dissolved in 5 ml of THF. 
To this solution, 0.252 g (347 µl) and 0.500 g NPC were added. The mixture was stirred 
for 24 hours and then centrifuged at 5000 rpm for 20 minutes to remove the salt. The 
supernatant was collected and rotovaporated to remove the solvent. The obtained dry 
product was further reacted with NH2-PEG-OCH3 (0.335 gm) in 5 ml of DMF at room 
temperature. After 72 hours, dialysis was performed for the purification of the final 
product using a 500 molecular weight cut off membrane (500 MWCO). The sample 
obtained after dialysis was freeze dried to get dry monomer 2 (EHMOPEG) with a yield of 
60%.   
 
Calculation:  
Weight of the intermediate product obtained = 281 g/ mole  
Amount of intermediate product being used = 0.05 g which is equivalent to 1.77*10-4 
moles 
Molecular weight of NH2-PEG-OCH3 being used = 2000 g/ mole 
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Since we want to keep the molar ratio as 1:1 therefore amount of PEG to be used = 0.335 
g (1.77*10-4 moles) 
 
 
 
 
Scheme 1:  PEGylated monomer synthesis 
 
3.3.2 Synthesis of polymer  
Cationic ring opening polymerization40, 41 was used for synthesis of hyperbranched 
polymer as shown in Scheme 2. The reaction was carried out in a three necked round 
bottom flask using a PTFE stirrer for mixing. The glassware used was washed well and 
dried in oven for few hours. The whole reaction set up was first degassed and dried 
completely by passing nitrogen from it for 30 minutes. The flask was placed on a heating 
mantle with temperature maintained at 100°C for first half an hour and then at 45°C for 
rest of the reaction. At 30 minutes, the nitrogen source was removed and the solvent, 
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dichloromethane (15 ml) and the catalyst BF3O(C2H5)2 were added to the flask. Within 
five minutes the monomer 1 was introduced and the flask temperature was maintained 
constant at 45°C. After the reaction was allowed for 48 hours, monomer 2 was added in to 
the flask and the reaction proceeded for another 24 hours. At the end of 72 hours the 
reaction was quenched by ethanol. The resultant polymer was dried in the vacuum oven at 
60°C for two days.  Four different poly(EHMO-EHMOPEG) co-polymers with various 
monomer 1: monomer 2  ratios (i.e.98.2:1.8 wt%, 96:4 wt%, 74.4:25.6 wt%, 17:83 wt%) 
were prepared. The first three polymers were prepared using EHMO modified with PEG 
chain of 2000 daltons and the last polymer with ratio 17:83 wt% (EHMO/EHMOPEG) was 
prepared using the monomer with a shorter PEG chain (MW= 550 daltons). This was done 
in order to reduce the steric hindrance in the polymerization and also to determine its 
influence on properties of the polymers. The yields of the obtained polymers ranged 
between 50-66% being highest for 98.2:1.8 and lowest for 17:83 polymeric ratios. The 
synthesized polymers are reproducible. 
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Scheme 2: Polymer synthesis 
 
3.3.3 Preparation of polymeric particles 
Single oil-in-water (O/W) emulsion/ solvent evaporation method23, 42 was used to obtain 
blank and drug loaded nanoparticles. The synthesized polymers (10 mg) were dissolved in 
1 ml of chloroform and 2 ml of DI water was drop wise added under magnetic stirring to 
prepare the blank particles.23  
Camptothecin, a hydrophobic anti cancer drug,43, 44 was used as the model drug. Drug 
solution was prepared by dissolving 10 mg of drug in a mixture of chloroform: methanol 
(4:1). Drug loaded nanoparticles were prepared by adding the drug solution (10 mg/ml) to 
the polymer solution (10 mg/3 ml). The mixture was kept at room temperature overnight. 
The equilibrated solution was then rotovaporated to remove the solvents. The particles 
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subjected to centrifugation for 1 hour at 13,200 rpm were collected and dried completely 
under vacuum. 
 
3.4 Characterization 
3.4.1 Nuclear magnetic resonance spectroscopy 
1H and 13C NMR spectra were taken to confirm the synthesis of the monomer and the 
polymer on a 400 MHz Bruker NMR instrument. Chloroform-d6, DMSO- d6, D2O were 
used as solvents and tetramethylsilane (TMS) was used as an internal standard. Processing 
of the data obtained was performed using “spin works” (free software) software courtesy 
of the University of Manitoba, Canada.  The chemical shifts for the respective solvents are 
as follows:  
Table 3: NMR shifts for commonly used solvents 
NMR spectroscopy solvent Chemical shift (ppm) 
D2O  
DMSO- d6 40.4 
Carbon shifts 
Chloroform- d6 77.3 
D2O 4.8 
DMSO- d6 2.5 
Proton shifts 
Chloroform- d6 7.2  
     
Degree of branching was also calculated using 13C-NMR. The triplet peaks obtained at 43 
ppm were integrated to obtain the values. Integration of the first peak, second peak and the 
third peak provided the values for the dendritic(D) units, Linear(L) unit, and the 
terminal(T) units as shown in Figure 8.  
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3.4.2 Differential scanning calorimetry 
 
DSC Q-1000 (TA instrument) was used for thermal analysis by determining glass 
transition temperature (Tg) and melting temperatures (Tm) of the synthesized polymers. 
Samples were prepared by placing 5-6 mg of polymers in hermetic pans with lids. In the 
process, the samples were first equilibrated at -40°C and then ramped up to 100°C using a 
heating rate of 10°C per minute and then cycle 2 was run at a cooling rate of 10°C per 
minute. The data included is after cycle 2. 
 
3.4.3 Fourier transform infrared spectroscopy 
FT-IR was also run on a Nicolet magna IR 760 spectrometer to identify and determine the 
different groups present in the polymer synthesized. Plots of % transmission and 
wavelength were plotted. Samples were prepared by placing 1-2 mg of polymer on the KBr 
(potassium bromide) disc and drying it with a drier. 
 
3.4.4 Dynamic light scattering 
Zetasizer Nano ZS Instrument from Malvern Instruments was used to determine the size of 
the particles and molecular weight of the polymer.45, 46  Dynamic light scattering is a 
noninvasive method which works on the principle of light scattering and determines the 
molecular weight and size of the particles by enforcing the Rayleigh equation.45, 46 Laser is 
used as the light source. When the light falls on the particles, scattering of light takes place 
and molecular weight is determined by the measurement of the time averaged intensity of 
scattered particles.  The working principle of the process is as shown in the Figure 9.47  
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Figure 9: Working principle of DLS 
 
Intensity of the scattered light is proportional to the product of the weight average 
molecular weight and the concentration of the solution. Debye plot between intensity of 
scattered light and concentration is used for the calculation. The intercept yields the inverse 
of the weight average molecular weight and toluene is used as the standard due to its high 
Rayleigh ratio which helps in accurate measurement. 45, 48 
 
Rayleigh equation: 
KC/R = (1/M + 2A2C) P 
 
Laser Focussing lens Particle dispersion
Scattered light Coherence optics
Photon detectorCorrelator
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From Debye plot: 
KC/R is proportional to 1/ (molecular weight in Daltons) 
The size of the particles was obtained on the basis of the same principle. Samples for blank 
nanoparticle size measurement studies were prepared by dissolving 1 mg of polymer in 
1ml of chloroform and then adding 2 ml water under magnetic stirring at room 
temperature.  
3.4.5 Scanning electron microscopy 
SEM was performed at the department of Anatomy and Neurobiology, (facility funded by 
NIH-NINDS Center core grant 5P30NS047463 and NIH-NCRR grant 1S10RR022495) to 
observe the morphology of the blank and drug loaded nanoparticles and also estimate their 
diameter. Zeiss EVO-50XVP model was used with an accelerating voltage of 10kV. 
Samples were prepared by putting few drops of the nanoparticle solution on a small cut 
silicon wafer and drying it for 6 hours in vacuum. Each sample was gold sputter coated 
(EMS 550 Automated sputter coater, Electron Microscopy Sciences) prior to its use. The 
images were taken at 35000x magnification. The working principle of the scanning 
electron microscopy is as shown in Figure 10.49 
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Figure 10: Working principle of SEM 
3.5 Drug loading and encapsulation efficiency studies 
Camptothecin, an anticancer hydrophobic drug, was used as a model drug43, 44 Before 
conducting any drug release studies, a scanning curve for CPT (Figure 11) was taken out 
using 1mg/ml solution of CPT in a mixture of chloroform and methanol (4:1) and since the 
absorbance values were highest at a wavelength of 369 nm, it was used to plot the standard 
curve (Figure 12) using UV-visible spectrophotometer. UV-visible spectroscopy was used 
to determine the amount of CPT that was encapsulated by the nanoparticles prepared.23 
The drug loaded nanoparticles were weighed and divided in to three equal amounts.  Then 
all three samples were dissolved in a mixture of chloroform and methanol solvents (in the 
ratio of 4:1). The samples were centrifuged for one hour at a speed of 13,200 rpm. After 
one hour the absorbance values were measured at 369 nm. The drug encapsulation 
Laser Interferometer
Beam splitter
IR source Mirror
Mirror
Mirror
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Detector
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efficiency (EE) is defined as the percentage of the drug in the nanoparticle with respect to 
the total amount of drug used and the loading efficiency (LE) is measured as the amount of 
drug encapsulated in the nanoparticle with respect to the total amount of the nanoparticles 
as shown in the following equations.23, 50  
 
EE = (Total amount of CPT- Free amount of CPT) / Total amount of CPT   
LE= (Total amount of CPT- Free amount of CPT) / Total amount of nanoparticle 
 
3.6 Cytotoxicity studies 
To evaluate the cytotoxicity of the synthesized polymeric particles, human dermal 
fibroblasts (obtained from Dr. Gary L. Bowlin’s lab, Biomedical Engineering department, 
VCU) cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) were used. The fibroblasts cells were incubated with blank 
polymeric particles at different concentrations (0.01µg/µl, 0.05µg/µl, 0.1µg/µl, and 
0.33µg/µl) at 37 °C for 48 hours. The cell viability was assessed with the MTT assay. 
Another cellular assay (MTT test) was performed to determine the efficacy of the drug 
loaded particles on the HN12 cells (derived from metastatic Squamous Cell Carcinoma). In 
this study, poly(EHMO-EHMOPEG)50:1 with a final concentration of 0.01µg/µl was studied 
 
3.7 Drug release study 
Drug loaded polymeric particles were weighed and dissolved in 10 ml of PBS buffer in a 
capped conical flask. The solution was maintained at 37 °C.  At predetermined intervals 
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the entire solution was centrifuged at 3500 rpm for 15 minutes. Afterwards, 3 ml of 
supernatant was collected and subjected to UV-visible measurement at 369 nm to quantify 
the released drug. After each measurement, 3 ml of fresh PBS buffer was added back to 
medium.23The drug release was calculated in terms of cumulative release by keeping in to 
account the amount withdrawn at every measurement point. The concentration  of drug at 
each time point was calculated using the standard curve (Figure 12).  
 
Calculation: 
  
 
 
 
 
 
 
 
 
 
 
 28 
0
0.5
1
1.5
2
2.5
3
3.5
0 200 400 600 800 1000 1200
wavelength (nm)
A
b
s
o
r
b
a
n
c
e
 
Figure 11: UV-Vis Scan of CPT (1 mg/ ml) 
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Figure 12: Standard Calibration Curve of CPT (360 nm) 
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CHAPTER 4 RESULTS AND DISCUSSION 
 
4.1 Preparation and characterization of EHMOPEG and poly(EHMO- EHMOPEG) 
NMR spectroscopy (400 MHtz) was used to confirm the synthesis of the PEGylated 
monomer and the poly(EHMO- EHMOPEG). In the 1H-NMR of the monomer 1, EHMO 
(Figure 13b), the peak at 4.3ppm is distinctive of the protons present in the oxetane ring of 
the EHMO. 1H-NMR for the monomers (Figure 13) displayed the following peaks which 
correspond to the respective groups.  
Table 4: 1H-NMR shifts for monomer characterization  
Chemical shift (ppm) Group(s) 
4.4  -CH2 groups of the oxetane ring 
0.9 -CH3 group on the oxetane side chain 
1.7 -CH2 group on the oxetane side chain 
3.7 -CH2-OH 
      
According to 1H-NMR spectrum of the polymer (Figure 14 B), disappearance of the peak 
at 4.3ppm indicates the occurrence of the ring opening polymerization.  
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The following other peaks were also observed: 
Table 5: 1H-NMR for polymer characterization  
Chemical shifts (ppm) Group(s) 
0.9 -CH3 groups 
1.7    -CH2 groups 
3.1  -CH2-O group 
3.3   -CH2-OH 
3.8   -OH group 
3.5   -(CH2CH2) group 
3.75    -(OCH3) group 
5-8  -(NH) group 
 
Table 6: 13C-NMR for polymer characterization  
Chemical shifts (ppm) Group(s) 
9.9 -CH3 groups 
21.8  -CH2 groups 
43   -D+L+T groups 
72    -(CH2CH2) groups 
62  -CH2OH group 
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Figure 13: 1H-NMR spectra of monomers 
a) EHMOPEG 
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Figure 14: NMR spectra of different polymeric ratios 
A) 13C-NMR spectrum of poly(EHMO-EHMOPEG2000)98.2:1.8 
a
b
f
c
c
de
 
B) 1H-NMR spectrum of poly(EHMO-EHMOPEG2000)98.2:1.8  
a
bc
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C) 13C-NMR spectrum of poly(EHMO-EHMOPEG2000)96:4 
a
b
f
c
d
e
c
 
 
D) 1H-NMR spectrum of poly(EHMO-EHMOPEG2000)96:4 
a
b
c
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E) 13C-NMR spectrum of poly(EHMO-EHMOPEG2000)74.4:25.6 
a
b
f
c
c
d
e
 
F) 1H-NMR spectrum of poly(EHMO-EHMOPEG2000)74.4:25.6 
a
b
c
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G) 13C-NMR spectrum of poly(EHMO-EHMOPEG550)17:83  
ab
f
c
c
d
e`
 
H) 1H-NMR spectrum of poly(EHMO-EHMOPEG550)17:83 
a
b
c
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4.2 Degree of branching 
The major attraction of the polymer synthesized is its hyperbranched characteristic. We 
can calculate its degree of branching using the following equation: 
    DOB = (D+T)/ (D+L+T)   
D, L, T represent the dendritic (D), linear (L) and the terminal (T) units of the 
hyperbranched polymer (as described earlier in Figure 8). The DOB is calculated by the 
integration of the peaks for the D, L and T units found around 43ppm in the carbon-13 
NMR (Figure 15 A,B,C and D). Degree of branching obtained for various ratios is shown 
in Table 7. The results indicate that the degree of branching increases with increase in 
monomer 2 which contributes mostly to the branches of the polymer.  
 
 
Table 7: Degree of branching of various polymeric ratios 
Polymer Degree of Branching 
Poly(EHMO-EHMOPEG2000)98.2:1.8 17.9 % 
Poly(EHMO-EHMOPEG2000)96:4 48.47% 
Poly(EHMO-EHMOPEG2000)74.4:25.6 76.4% 
Poly(EHMO-EHMOPEG550)17:83 78% 
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Figure 15: NMR spectra of Degree of branching 
A) poly(EHMO-EHMOPEG2000)98.2:1.8 
 
B) poly(EHMO-EHMOPEG2000)96:4 
 
C) poly(EHMO-EHMOPEG2000)74.4:25.6 
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D) poly(EHMO-EHMOPEG550)17:83 
 
 
4.3 Mechanisms governing the reactions 
 39 
The synthesis of the hyperbranched polymer is governed by two mechanisms known as 
Active Chain End mechanism (ACE) and Activated Monomer Mechanism (AMM). 
Polymerization is initiated by protonation of the oxygen atom in the oxetane ring which is 
attacked (nucleophilic) by the free hydroxyl group present on monomer 1 (EHMO). Active 
monomer mechanism leads to the formations of the branched core structure whereas the 
active chain mechanism contributes to the formation of the linear hydrophilic branches as 
shown in Scheme 3 below. 
 
 
Scheme 3: Mechanism of polymer synthesis  
A) Initiation  
 
 
 
 
 
 
 
 
B) Propagation via AMM mechanism 
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C) ACE mechanism 
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D) Termination  
 
 
 
4.4 Fourier transform infrared spectroscopy 
From the data obtained for FT-IR, we observed strong transmittance peaks at 2880 cm-1 for 
alkane groups, and at 1110.4 cm-1 for ether groups. A stretching peak at 1740 cm-1 was 
also observed for C=O bond. The results obtained from FT-IR confirm that the polymer 
synthesis.  
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Figure 16: FT-IR plots for different polymeric ratios 
A) Poly(EHMO-EHMOPEG2000)98.2:1.8 
010002000300040005000
cm -1
 
B) Poly(EHMO-EHMOPEG2000)96:4 
010002000300040005000
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C) Poly(EHMO-EHMOPEG2000)74.4:25.6 
010002000300040005000
 
 
D) Poly(EHMO-EHMOPEG550)17:83 
010002000300040005000
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4.5 Differential scanning calorimeter  
Thermal transitions were studied using differential scanning calorimetry. Glass transition 
temperatures were recorded as shown in Table 8. The glass transition temperature 
decreased with increase in the degree of branching. Glass transition temperature is 
influenced by free volume available for the motion of the chains and free chain ends.38 
PEG chains have a low Tg at -32 °C due to which the values for Tg keeps on decreasing as 
the amount of monomer 2 which has a PEG chain attached to it increases.  
 
Table 8: Glass transition temperatures 
Polymer Glass transition temperature 
Poly(EHMO-EHMOPEG2000)98.2:1.8 (a) -31.5 °C 
Poly(EHMO-EHMOPEG2000)96:4 (b) -53.5 °C 
Poly(EHMO-EHMOPEG2000)74.4:25.6 (c) -43.5 °C 
Poly(EHMO-EHMOPEG550)17:83 (d) -55.5 °C 
 
 
 
 
 
 
 
 
 46 
Figure 17: DSC curves 
A) poly(EHMO-EHMOPEG2000)98.2:1.8 
 
 
 
 
 
 
 
 
 
Temperature (°C) 
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B) poly(EHMO-EHMOPEG2000) 96:4 
 
 
 
 
 
 
 
 
 
 
 
 
 48 
C) poly(EHMO-EHMO PEG2000)74.5:25.6 
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D) poly(EHMO-EHMOPEG550)17:83 
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E) Combined curve for all the polymers 
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4.6 Molecular weight  
 
Dynamic light scattering (DLS) was also used to determine the molecular weight of the 
polymers using toluene as the standard. The weights determined from DLS were as shown 
in Table 9. The results show that the molecular weight keeps increasing as the degree of 
branching and amount of monomer 2 increases. 
  
Table 9: Molecular weight determined from DLS 
Polymer Molecular weight 
Poly(EHMO-EHMOPEG2000)98.2:1.8 20.96 kDa  
Poly(EHMO-EHMOPEG2000)96:4 28.1 kDa 
Poly(EHMO-EHMOPEG2000)74.4:25.6 34.34 kDa 
Poly(EHMO-EHMOPEG550)17:83 7.8 kDa 
 
 
 
4.7 Preparation of polymeric particles  
Both blank and drug loaded nanoparticles were prepared by the method described earlier 
and their morphology and size were characterized using SEM (scanning electron 
microscopy) and DLS (dynamic light scattering). SEM images (Figure 18) shows that the 
particles were mostly circular in shape and the diameter ranged from 200 nm to 500 nm 
depending upon the copolymer composition. The spherical shape of the particles was 
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maintained after the drug was encapsulated. DLS was also used to provide quantitative size 
information. The size of polymeric particles obtained from DLS ranged between 250 nm 
and 700 nm and were found to be consistent with the SEM results. The difference in size 
measured by both techniques was possibly due to the method by which the samples were 
prepared for SEM. Since the samples were obtained by putting a few drops of the solution 
on silicon wafers and then drying them in the vacuum oven for 4-6 hours, there is a 
possibility that the drying might have caused the shrinkage of the particles.23, 25  The size of 
the drug loaded particles was bigger than that of the blank particles indicating the 
encapsulation of the drug into the particles as shown in the Figure 19.  
 
 
Table 10: Particle size determined using DLS and SEM 
Blank particle sizes DLS (nm) SEM (nm) 
Poly(EHMO-
EHMOPEG2000)98.2:1.8 
685.5 ± 5.25 450-550  
Poly(EHMO-
EHMOPEG2000)96:4 
509 ± 5.50 480-450  
Poly(EHMO-
EHMOPEG2000)74.4:25.6 
361 ± 7.20 150-200  
Poly(EHMO-
EHMOPEG550)17:83 
1078 ± 5.60 900-1000  
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The particle size was found to be decreasing with increase in the amount of monomer 2 
which mostly form the hydrophilic branches of the polymer. This behavior is in 
accordance to the Eisenberg et al. theory 42 which says that thermodynamics of aggregation 
governs the size of the micelles. They proposed three sources which may influence the 
behavior of micelles namely, the core, core-solvent interaction, and shell-solvent 
interaction.  
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Figure 18: SEM images of blank polymeric particles  
A) Poly(EHMO-EHMOPEG2000)98.2:1.8 
 
B) Poly(EHMO-EHMOPEG2000)96:4 
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C) Poly(EHMO-EHMOPEG2000)74.4:25.6 
 
 
D) Poly(EHMO-EHMOPEG550)17:83 
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Figure 19: Comparison study between blank and drug loaded particles:  
A) Poly(EHMO-EHMOPEG2000)98.2:1.8  
Before drug encapsulation 
 
 
After drug encapsulation 
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B) Poly(EHMO-EHMOPEG2000)96:4   
Before drug encapsulation 
 
 
 
After drug encapsulation 
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C) Poly(EHMO-EHMOPEG2000)74.4:25.6  
Before drug encapsulation 
 
 
 
 
 
After drug encapsulation 
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D) Poly(EHMO-EHMOPEG550)17:83 
Before drug encapsulation 
 
 
 
 
 
After drug encapsulation 
 
 
 
 60 
4.8 Cytotoxicity studies 
Cytotoxicity tests were performed using human dermal fibroblasts cells. Positive control 
was used, where the fibroblast cells were incubated with zero concentration of polymer. 
The studies clearly indicated that addition of PEG to the polymer reduced the cytotoxicity 
of the material. Cell viability was the highest for the polymer with the maximum amount 
of PEG i.e. poly(EHMO-EHMOPEG550)17:83 as shown in Figure 20. Cell images (Figure 21) 
confirm that the cells incubated were not affected in terms of morphology. As seen in both 
cell viability assay and cell imaging analysis poly(EHMO-EHMOPEG550)17.83 was the least 
toxic. Figure 21 further shows the effect of increasing concentrations (from 0.01 µg/µl to 
0.33 µg/µl) of different polymeric ratios on the fibroblast cells. The cytotoxicity studies 
suggest the cytotoxicity of the polymeric particles is dose and composition dependent.  
 
Figure 20: Cytotoxicity studies  
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Figure 21: Microscopic images for cytotoxicity studies 
A) Poly(EHMO-EHMOPEG2000)98.2:1.8 
i) 0.01µg/µl 
 
 
ii) 0.05µg/µl 
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iii) 0.1µg/µl 
 
 
 
iv) 0.33µg/µl 
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B) Poly(EHMO-EHMOPEG2000)96:4 
i) 0.01µg/µl 
 
 
 
ii) 0.05µg/µl 
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iii) 0.1µg/µl 
 
 
iv) 0.33µg/µl 
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C) Poly(EHMO-EHMOPEG2000)74.4:25.6  
i) 0.01µg/µl 
 
 
ii) 0.05µg/µl 
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iii) 0.1µg/µl 
 
iv) 0.33µg/µl 
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D) Poly(EHMO-EHMOPEG550)17:83 
 
i) 0.01µg/µl 
 
 
 
ii) 0.05µg/µl 
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iii) 0.1µg/µl 
 
 
 
iv) 0.33µg/µl 
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CHAPTER 5 DRUG RELEASE KINETICS 
 
5.1 Loading and encapsulation studies 
Camptothecin (CPT), an anticancer hydrophobic drug was used as the model drug.  
Loading and encapsulation efficiencies were calculated for the different polymeric ratios 
and the results were as shown. The DOB increase caused to decrease the size of the core of 
the particles which, in turn led to the decrease in loading capacity.23 
 
Table 11: Loading efficiencies  
Polymer Loading efficiencies in % 
Poly(EHMO-EHMOPEG2000)98.2:1.8 80 
Poly(EHMO-EHMOPEG2000)96:4 73.8 
Poly(EHMO-EHMOPEG2000)74.4:25.6 65 
Poly(EHMO-EHMOPEG550)17:83 66 
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Table 12: Incorporation Efficiencies 
Polymer Incorporation Efficiency in % 
Poly(EHMO-EHMOPEG2000)98.2:1.8 66 
Poly(EHMO-EHMOPEG2000)96:4 65 
Poly(EHMO-EHMOPEG2000)74.4:25.6 64 
Poly(EHMO-EHMOPEG550)17:83 60 
 
 
5.2 Drug release study  
The drug release kinetics as shown in Figure 22, indicates that all poly(EHMO-EHMOPEG) 
polymeric particles display a similar release pattern. A small burst effect takes place in the 
beginning between 1 to 20 hours and then a controlled and sustained release is observed. 
The order of release kinetics ranges from 0.3 to 0.7. The burst effect as observed in the 
beginning can be attributed to rapid diffusion of the drug that did not get trapped in the 
core. Therefore, the drug in the outer shell or on the surface released faster whereas, the 
core encapsulated drug releases at a much sustained manner. Since the drug used is a 
hydrophobic drug, hydrophobic interactions are the main reason for the controlled drug 
release. The release of the drug is also related to the degree of branching of the synthesized 
polymers. As indicated Figure 22, the release rate decreases with the increase in degree of 
branching. As the DOB increases, it causes more obstruction in the release of the drug and 
also causes the size of the particles to decrease as explained above. As a consequence the 
release rate also decreases. The release of the drug is mostly governed by diffusion of 
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water across the branched polymer. However, steric hindrance was also observed to have 
an influence over the drug release rate. The polymer with PEG550 (Poly(EHMO-
EHMOPEG)17:83) was found to have a higher release rate than the polymer with PEG2000 
(Poly(EHMO-EHMOPEG)74.4:25.6). This indicates that the drug release was slowed down by 
the presence of lengthier PEG chains. 
Figure 22: Drug release kinetics  
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5.3 Cellular assay 
Cellular assay was performed on HN12 cells to determine the efficacy of the encapsulated 
drug. MTT test conducted with 0.5µg/µl of concentration of poly(EHMO-
EHMOPEG2000)74.4:25.6 showed that as the time increased from 12 to 72 hours the amount of 
cellular activity reduced indicating the release of drug from the particles as shown in 
Figure 23. The release was controlled and took place slowly over a period of time as 
indicated by the drug release studies. The percentage of the cellular activity became as low 
as 10% after 72 hours which indicated high potency of the drug.  
 
Figure 23: Cellular assay 
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5.4 Conclusions 
A new family of amphiphilic core-corona hyperbranched polymer, composed of EHMO 
and PEGylated EHMO was synthesized through cationic ring opening polymerization. It 
was characterized with NMR, FT-IR, DLS and DSC. Oil in water emulsion method was 
applied to formulate the synthesized polymers into particles for drug delivery. 
Degree of branching was found to be dependent on the weight % ratio of 
EHMO/EHMOPEG and has a significant impact on polymeric properties including glass 
transition temperature, and drug loading efficiency. CPT can be released at a controlled 
and sustained rate. Addition of PEG chains to the polymer reduced the toxicity of the 
resulting hyperbranched polymer and made them more biocompatible. 
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CHAPTER 6 SUMMARY AND FUTURE WORK 
 
 Hyperbranched polymers have unique physical and chemical properties due to 
which they find potential applications in various fields including drug delivery to 
coatings.26 They possess highly branched and three dimensional dendritic architecture, 
which makes them highly adaptable. We synthesized a novel amphiphilic polymeric 
system with potential for drug delivery and controlled release. We demonstrated the effect 
of addition of the monomer 2 (monomer with PEG chains) on the thermal properties, 
mechanical properties and drug release kinetics. We used Camptothecin, an anticancer 
hydrophobic drug for drug release studies; various other hydrophobic drugs can be used for 
future studies. All the studies done here were in vitro, therefore future studies must be done 
in vivo to get a better insight into how to utilize the synthesized polymeric system in 
human. Thermal analysis was done in this study to determine glass transition temperatures 
and its influence on the material. Further studies can be done to determine if the polymeric 
system shows any thermoresponsiveness. 
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